Geron | GERN - Operating Expenses

Stock Price
1.30
Daily Change
-0.11 -7.50%
Monthly
-23.37%
Yearly
1.97%
Q2 Forecast
1.36

Geron reported $52.07M in Operating Expenses for its fiscal quarter ending in March of 2026.





Operating Expenses Change Date
Amgen USD 4.78B 1.12B Mar/2026
Bio Techne USD 235.92M 5.5M Mar/2026
Cassava Sciences USD 13.55M 1.69M Dec/2025
Cytokinetics USD 200.58M 4.46M Mar/2026
Esperion Therapeutics USD 83.21M 14.06M Dec/2025
Exelixis USD 359.47M 3.28M Mar/2026
Genmab DKK 798M 235M Dec/2025
Geron USD 52.07M 6.73M Mar/2026
Gilead Sciences USD 23.52B 18.55B Mar/2026
Incyte USD 5.62B 4.5B Mar/2026
MacroGenics USD 21.2M 32.13M Mar/2026
Novartis USD 9.29B 507M Mar/2026
Novavax USD 126.2M 23.62M Dec/2025